Switch to:
More From Other Websites
NovaBay Signs Avenova Distribution Agreement with Cardinal Health Jan 26 2015
NovaBay Signs Avenova Distribution Agreement with Cardinal Health Jan 26 2015
NovaBay Signs Avenova Distribution Agreement with Cardinal Health Jan 26 2015
NovaBay Will Expand Marketing for Avenova At Arab Health 2015 Jan 23 2015
NovaBay Will Expand Marketing for Avenova At Arab Health 2015 Jan 23 2015
NovaBay Management and Key Industry Opinion Leaders to Hold Investment Community Conference Call... Jan 21 2015
NovaBay Management and Key Industry Opinion Leaders to Hold Investment Community Conference Call... Jan 21 2015
NovaBay Expands Sales Force for Avenova Jan 20 2015
NovaBay Expands Sales Force for Avenova Jan 20 2015
NovaBay Announces New Business Strategy Focusing on Products for Eye Care Jan 07 2015
NovaBay Announces New Business Strategy Focusing on Products for Eye Care Jan 07 2015
NovaBay Rebrands Its i-Lid Cleanser as Avenova Jan 05 2015
NovaBay Rebrands Its i-Lid Cleanser as Avenova Jan 05 2015
NovaBay Executive Officers Report Insider Buying of 143,000 Common Shares to the SEC Dec 23 2014
Christmas Gift to People Worldwide Suffering From “Flesh Eating” Disease: NovaBay... Dec 23 2014
Christmas Gift to People Worldwide Suffering From "Flesh Eating" Disease: NovaBay Pharmaceuticals... Dec 23 2014
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New... Dec 19 2014
NovaBay Executive Officers Report Insider Buying of 143,000 Common Shares to the SEC Dec 16 2014
NovaBay Signs Distribution Agreement With the Biopharm Group Dec 08 2014
NovaBay Signs Distribution Agreement With the Biopharm Group Dec 08 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK